Option exercised on undisclosed immune-oncology target following evaluation period by Moderna -
- Autolus receives option exercise fee, with potential for development milestone payments plus royalties -
https://finance.yahoo.com/news/moderna-exercises-option-license-proprietary-110000823.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.